Department of Biomedical Engineering, Orthopaedic and Rheumatologic Research Center, Cleveland Clinic Foundation, Cleveland, OH, USA.
Clin Orthop Relat Res. 2012 Sep;470(9):2513-21. doi: 10.1007/s11999-012-2348-x.
Scaffold devices are used to augment rotator cuff repairs in humans. While the strength of a novel poly-L-lactic acid-reinforced (human) fascia patch has been documented, it is unclear whether such patches will enhance the strength or likelihood of healing of rotator cuff repairs.
QUESTIONS/PURPOSES: In a canine shoulder model, we asked: Do tendon repairs augmented with a reinforced fascia patch have (1) increased biomechanical properties at Time 0 and (2) less tendon retraction and increased cross-sectional area and biomechanical properties after 12 weeks of healing compared to repairs without augmentation? (3) Do the biomechanical properties of tendon repairs reach normal values by 12 weeks of healing? And (4) is the host response associated with use of the reinforced fascia patch biocompatible?
Eleven dogs underwent bilateral shoulder surgery with partial release and acute repair of the infraspinatus tendon, one shoulder with augmentation and one without augmentation. Repair retraction, cross-sectional area, biomechanical properties, and biocompatibility were assessed at 12 weeks.
At Time 0, the mean ± SD ultimate load of augmented repairs was 296 ± 130 N (46% ± 25%) more than nonaugmented repairs, with no difference in stiffness between groups. At 12 weeks, the ultimate load of augmented repairs averaged 192 ± 213 N (15% ± 16%) less than nonaugmented repairs, with no difference in stiffness between groups. At the tendon repair site at 12 weeks, the fascia patch showed a biocompatible host tissue response.
The biomechanical properties of repairs augmented with a reinforced fascia patch demonstrated greater ultimate load at Time 0 than nonaugmented repairs but remained essentially unchanged after 12 weeks of healing, despite improvements in the ultimate load of nonaugmented controls in the same time frame.
支架设备用于增强人类肩袖修复。虽然新型聚 L-丙交酯增强(人)筋膜补片的强度已得到证实,但尚不清楚此类补片是否会增强肩袖修复的强度或愈合可能性。
问题/目的:在犬肩部模型中,我们提出以下问题:(1)增强型筋膜补片增强的肌腱修复在时间 0 时具有增加的生物力学特性吗?(2)与未增强修复相比,修复后的肌腱回缩更少、横截面积增加且生物力学特性更好吗?(3)肌腱修复的生物力学特性是否在 12 周愈合后达到正常水平?(4)增强型筋膜补片的使用与宿主反应相关吗?
11 只狗接受双侧肩部手术,行肩胛下肌部分释放和急性修复,一侧肩部增强修复,另一侧不增强。在 12 周时评估修复回缩、横截面积、生物力学特性和生物相容性。
在时间 0 时,增强修复的最大负载平均为 296 ± 130 N(46% ± 25%),明显大于非增强修复,但两组之间的刚度无差异。在 12 周时,增强修复的最大负载平均为 192 ± 213 N(15% ± 16%),明显小于非增强修复,但两组之间的刚度无差异。在 12 周时,在肌腱修复部位,筋膜补片表现出生物相容性的宿主组织反应。
增强型筋膜补片增强的修复在时间 0 时的最大负载大于非增强修复,但在 12 周愈合后基本保持不变,尽管在同一时间框架内非增强对照组的最大负载有所改善。